Breast Imaging: Page 28

Breast MRI's better cancer detection outweighs false-positive 'harm'
By Kate Madden Yee
Breast MRI can produce more false positives on initial screening in women at higher cancer risk -- an outcome many consider a "harm" -- but patients and their doctors may decide this is justified by the modality's higher cancer detection rate, according to a study published May 15 in Clinical Imaging.
May 27, 2020
2019 07 22 20 17 2160 Mri Breast 400
AMVC 2020: A look at breast imaging in 2020
New technologies like digital breast tomosynthesis, artificial intelligence, and abbreviated MRI are dramatically changing how breast imaging services are delivered in 2020. Dr. Emily Conant of the Hospital of the University of Pennsylvania offers a perspective.
May 14, 2020
2017 12 11 19 56 0988 Conant Emily 20171211193636 20200513235521
Bilateral breast MRI needed even after mastectomy
By Kate Madden Yee
Follow-up of breast cancer survivors with breast MRI should be bilateral, even in asymptomatic women who underwent mastectomy, according to a study published May 6 in the American Journal of Roentgenology.
May 7, 2020
2019 07 22 20 17 2160 Mri Breast 400
Another major study supports long-term DBT benefits
By Theresa Pablos
The evidence in support of digital breast tomosynthesis (DBT) just keeps rolling in. A recent study in Radiology found the technology sustained high specificity and low false-positive rates over multiple breast screening cycles.
April 28, 2020
2016 11 15 14 47 22 735 Breast Dbt 400
AI bolsters lesion assessment on breast ultrasound
By Erik L. Ridley
An artificial intelligence (AI)-based breast ultrasound software application can enhance the accuracy and consistency of lesion assessment for readers across a wide range of specialties and experience levels, according to research published online April 22 in the American Journal of Roentgenology.
April 23, 2020
2020 04 23 23 33 3240 2020 04 24 Ai Breast Us 20200423233617
DBT has lower recall rate in large U.S. study
By Theresa Pablos
Digital breast tomosynthesis (DBT) had significantly lower recall rates than digital mammography in a study published on March 30 in JAMA Network Open. The modality also had higher rates of breast cancer detection, suggesting the reduction in recalls wasn't because of missed cancer cases.
March 29, 2020
2016 11 15 14 47 22 735 Breast Dbt 400
Shorter MRI works for patients with breast cancer history
By Theresa Pablos
Breast MRI with a shorter screening protocol can still help detect cancer recurrence for women with a personal history of breast cancer, according to a study published on March 12 in PLOS One. Abbreviated MRI with an 11-minute protocol identified almost a dozen cancers missed by alternative screening modalities.
March 24, 2020
2017 05 18 14 19 41 644 Stopwatch Hand 400
Breast MRI works as presurgical tool
By Theresa Pablos
Breast MRI may improve surgical success for women with breast cancer, according to a study published on March 17 in Radiology. Patients who underwent presurgical MRI had fewer positive surgical margins and repeat surgeries than those who did not.
March 19, 2020
2019 07 22 20 17 2160 Mri Breast 400
ABUS leads to more cancer detection, higher recall rates
By Theresa Pablos
Radiologists who double read automated breast ultrasound scans (ABUS) on their own or in combination with digital breast tomosynthesis had higher cancer detection rates -- but their recall rates were also higher, according to a recent study in the Journal of Breast Imaging.
March 11, 2020
2020 01 02 17 50 4501 Breast Cancer3 400
Benefits of DBT for screening stand the test of time
By Theresa Pablos
The benefits of digital breast tomosynthesis (DBT) stand the test of time, according to a five-year retrospective study published on March 10 in Radiology. The study found DBT had better cancer detection and fewer false positives than digital mammography throughout multiple screening appointments.
March 11, 2020
2016 11 15 14 47 22 735 Breast Dbt 400
AuntMinnie.com Women's Imaging Insider
By Theresa Pablos
March 9, 2020
ScreenPoint gets FDA nod for Transpara 3D
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to ScreenPoint Medical for its Transpara 1.6.0 artificial intelligence clinical decision-support system for 2D mammography and 3D mammography, also known as digital breast tomosynthesis.
March 8, 2020
2020 03 09 19 57 8230 Screen Point Rsna 2019 400
Previous Page
Page 28 of 89
Next Page